Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Marianne Rudolph Hansen has worked on the following 20 EPO patent applications which have been published in the last five years:

EP11802239

METHODS OF HYDROLYZING OLIGOMERS IN HEMICELLULOSIC LIQUOR

IPC classification:
C12N 9/42, C12P 19/02, D21C 1/00
Applicant:
Novozymes North America, Inc.
Agent:
Multiple attorneys, Novozymes A/S
Status:
EXAMINATION IN PROGRESS
EP12710413

METHODS OF INCREASING THE CELLULOLYTIC ENHANCING ACTIVITY OF A POLYPEPTIDE

IPC classification:
C07K 14/37, C12P 7/10, C12P 19/10
Applicant:
Novozymes A/S
Applicant:
Novozymes Inc
Agent:
Multiple attorneys, Novozymes A/S
Status:
EXAMINATION IN PROGRESS
EP12765435

METHOD FOR DEGRADING OR CONVERTING CELLULOSIC MATERIAL

IPC classification:
C12N 9/08, C12N 9/42, C12N 15/53, C12N 15/56, C12S 3/04
Applicant:
Novozymes A/S
Agent:
Multiple attorneys, Novozymes A/S
Status:
GRANT OF PATENT INTENDED
EP12712209

CELLULOSE BINDING DOMAIN VARIANTS AND POLYNUCLEOTIDES ENCODING SAME

IPC classification:
C12N 9/42
Applicant:
Novozymes Inc
Agent:
Multiple attorneys, Novozymes A/S
Status:
GRANT OF PATENT INTENDED
EP12776771

POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME

IPC classification:
C07K 14/37, C12N 5/10, C12N 9/42, C12N 15/56, C12N 15/63, C12P 19/14
Applicant:
Novozymes Inc
Agent:
Multiple attorneys, Novozymes A/S
Status:
EXAMINATION IN PROGRESS
EP12722962

METHODS FOR ENHANCING THE DEGRADATION OR CONVERSION OF CELLULOSIC MATERIAL

IPC classification:
C11D 3/386, C12P 19/14
Applicant:
Novozymes Inc
Agent:
Multiple attorneys, Novozymes A/S
Status:
GRANT OF PATENT INTENDED
EP12723981

POLYPEPTIDES HAVING ENDOGLUCANASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME

IPC classification:
C12N 9/42
Applicant:
Novozymes A/S
Applicant:
Novozymes Inc
Agent:
Multiple attorneys, Novozymes A/S
Status:
EXAMINATION IN PROGRESS
EP12723068

METHODS FOR ENHANCING THE DEGRADATION OF CELLULOSIC MATERIAL WITH CHITIN BINDING PROTEINS

IPC classification:
C12P 7/10, C12P 19/02, C12P 19/04, C12P 19/14
Applicant:
Novozymes Inc
Agent:
Multiple attorneys, Novozymes A/S
Status:
GRANT OF PATENT INTENDED
EP12723067

METHODS FOR ENHANCING THE DEGRADATION OF CELLULOSIC MATERIAL WITH CHITIN BINDING PROTEINS

IPC classification:
C12P 7/10, C12P 19/02, C12P 19/12, C12P 19/14
Applicant:
Novozymes Inc
Agent:
Multiple attorneys, Novozymes A/S
Status:
GRANT OF PATENT INTENDED
EP12749154

POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME

IPC classification:
A01H 1/00, C07K 14/37, C12N 9/42, C12N 15/56, C12N 15/63, C12P 19/00, C12P 19/14
Applicant:
Novozymes Inc
Agent:
Multiple attorneys, Novozymes A/S
Status:
EXAMINATION IN PROGRESS
EP13791808

OLIGONUCLEOTIDE CONJUGATES

IPC classification:
C12N 15/11, C12N 15/113
Applicant:
Roche Innovation Center Copenhagen A/S
Agent:
Marianne Rudolph Hansen, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13794852

ANTI APOB ANTISENSE CONJUGATE COMPOUNDS

IPC classification:
A61P 3/06, C12N 15/11, C12N 15/113
Applicant:
Roche Innovation Center Copenhagen A/S
Agent:
Marianne Rudolph Hansen, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13795243

COMPOSITIONS AND METHODS FOR MODULATION OF FGFR3 EXPRESSION

IPC classification:
A61K 31/7125, C07H 21/00, C12N 15/113
Applicant:
Roche Innovation Center Copenhagen A/S
Agent:
Marianne Rudolph Hansen, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP14704307

LNA OLIGONUCLEOTIDE CARBOHYDRATE CONJUGATES

IPC classification:
A61K 31/712, C12N 15/113
Applicant:
F. Hoffmann-La Roche AG
Agent:
Marianne Rudolph Hansen, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14726003

OLIGONUCLEOTIDE MODULATORS OF B-CELL CLL/LYMPHOMA 11A (BCL11A) AND USES THEREOF

IPC classification:
C12N 15/113
Applicant:
Roche Innovation Center Copenhagen A/S
Agent:
Marianne Rudolph Hansen, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP13163795

Purification process

IPC classification:
C07K 14/79
Applicant:
Novozymes Biopharma DK A/S
Agent:
Marianne Rudolph Hansen, Novozymes A/S
Agent:
Rachel Clare Williams, Novozymes Biopharma UK Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14739708

ANTISENSE OLIGOMERS AND CONJUGATES TARGETING PCSK9

IPC classification:
A61K 31/712, A61P 3/06, C12N 15/113
Applicant:
Roche Innovation Center Copenhagen A/S
Agent:
Zacco Denmark A/S
Agent:
Marianne Rudolph Hansen, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14799402

APOB ANTISENSE CONJUGATE COMPOUNDS

IPC classification:
A61K 31/7088, C12N 15/113
Applicant:
Roche Innovation Center Copenhagen A/S
Agent:
Marianne Rudolph Hansen, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP16184264

SMALL MOLECULE CONJUGATES FOR INTRACELLULAR DELIVERY OF NUCLEIC ACIDS

IPC classification:
A61K 31/713, A61K 47/18, A61K 48/00, C07H 21/02, C12N 15/11, C12N 15/87
Applicant:
F. Hoffmann-La Roche AG
Agent:
Marianne Rudolph Hansen, F. Hoffmann-La Roche AG
Status:
APPLICATION PUBLISHED
EP15778299

GALNAC PHOSPHORAMIDITES, NUCLEIC ACID CONJUGATES THEREOF AND THEIR USE

IPC classification:
C07H 15/04, C07H 15/08, C07H 21/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Marianne Rudolph Hansen, F. Hoffmann-La Roche AG
Status:
Request for examination was made

Please Sign in to use this feature